Michael J. Mauro

MedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias”.

Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias

New England Journal of Medicine(2012)10.1056/nejmoa1205127

N/A

0.998DataRank · unranked

773 citations

Hagop Kantarjian, Neil P. Shah, Dale Bixby, Michael J. Mauro, Ian Flinn +11 more

Treatment‐free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5‐year analysis of DASFREE

British Journal of Haematology(2023)10.1111/bjh.18883

N/A

0.866DataRank · unranked

23 citations

Valentín García‐Gutiérrez, Antonio Jiménez‐Velasco, Sarah Larson, Susanne Saußele, Delphine Réa +8 more

Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2628

N/A

0DataRank · unranked

4 citations

Jörge E. Cortes, Jane F. Apperley, Mel Mann, Michael J. Mauro, Vivian G. Oehler +11 more

Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition

Haematologica(2020)10.3324/haematol.2020.249649

N/A

0DataRank · unranked

37 citations

Lianrong Xu, Umut Aypar, Howard Meyerson, Dory Londono, Qi Gao +12 more

Project Confirm: Accelerated Drug Approvals for CML—Response

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3234

N/A

0DataRank · unranked

0 citations

Jörge E. Cortes, Jane F. Apperley, Mel Mann, Michael J. Mauro, Vivian G. Oehler +12 more

Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia

Nature Reviews Clinical Oncology(2025)10.1038/s41571-025-01068-0

N/A

0DataRank · unranked

12 citations

Ellen Weisberg, Hiu Yan Lam, Donavan J. J. Tan, Andrew J. Innes, Yubin Ge +17 more

The Influence of Body Fat Dynamics on Pulmonary Immune Responses in Murine Tuberculosis: Unraveling Sex-Specific Insights

International Journal of Molecular Sciences(2024)10.3390/ijms25136823

N/A

0DataRank · unranked

2 citations

Hariprasad Thangavel, Tabinda Sidrat, Neelam Oswal, Kezia Lizardo, Michael J. Mauro +5 more

Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines

Leukemia(2021)10.1038/s41375-021-01457-1

N/A

0DataRank · unranked

6 citations

Linda Ouyang, Andriy Derkach, Alexandra Sherman, Susan J. McCall, Christopher Famulare +6 more